We are live on ! Find out more
Mackenzie Financial

Mackenzie Financial Portfolio holdings

AUM $100B
1-Year Est. Return 36.93%
This Fund
S&P 500
This Quarter Est. Return
+11.13%
1 Year Est. Return
+36.93%
3 Year Est. Return
+93.95%
5 Year Est. Return
+113.13%
10 Year Est. Return
+336.84%
AUM
$77.2B
AUM Growth
+$6.86B
Cap. Flow
+$436M
Cap. Flow %
0.56%
Top 10 Hldgs %
23.5%
Holding
1,822
New
156
Increased
763
Reduced
547
Closed
123

Top Buys

Rank Stock Value
1
MRSH
Marsh
MRSH
+$351M
2
NVDA icon
NVIDIA
NVDA
+$298M
3
EMA
Emera Inc
EMA
+$231M
4
AMZN icon
Amazon
AMZN
+$177M
5
FSV icon
FirstService
FSV
+$128M

Sector Composition

Rank Sector Weight
1 Financials 22.09%
2 Technology 21.8%
3 Industrials 11.13%
4 Healthcare 8.33%
5 Energy 7.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PACB icon
1676
Pacific Biosciences
PACB
$420M
$21.7K ﹤0.01%
17,499
+2,409
+16% +$2.78K
OPEN icon
1677
Opendoor
OPEN
$3.06B
$21.2K ﹤0.01%
41,036
-2,535
-6% -$1.83K
QIPT
1678
DELISTED
Quipt Home Medical
QIPT
$18.9K ﹤0.01%
10,575
OCGN icon
1679
Ocugen
OCGN
$461M
$18.2K ﹤0.01%
18,748
+2,648
+16% +$2.2K
CHPT icon
1680
ChargePoint
CHPT
$267M
$17.6K ﹤0.01%
1,252
BMY icon
1681
PUT
Bristol-Myers Squibb
BMY
$136B
$15.6K ﹤0.01%
+21,600
New +$1.06M
SBUX icon
1682
PUT
Starbucks
SBUX
$119B
$14.8K ﹤0.01%
+10,900
New +$945K
ERAS icon
1683
Erasca
ERAS
$5.66B
$14.1K ﹤0.01%
11,141
EAF icon
1684
GrafTech
EAF
$162M
$12.5K ﹤0.01%
1,283
MVIS icon
1685
Microvision
MVIS
$50.5M
$12.4K ﹤0.01%
728
ESPR
1686
DELISTED
Esperion Therapeutics
ESPR
$11.5K ﹤0.01%
11,700
-111,415
-90% -$112K
LCTX icon
1687
Lineage Cell Therapeutics
LCTX
$273M
$10.3K ﹤0.01%
+11,404
New +$6.76K
BBY icon
1688
PUT
Best Buy
BBY
$19B
$7.8K ﹤0.01%
+15,200
New +$1.03M
IRWD icon
1689
Ironwood Pharmaceuticals
IRWD
$704M
$7.5K ﹤0.01%
10,460
IAUX
1690
i-80 Gold Corp
IAUX
$1.55B
$7.28K ﹤0.01%
12,158
CVS icon
1691
PUT
CVS Health
CVS
$124B
$6.94K ﹤0.01%
+15,000
New +$984K
TGT icon
1692
PUT
Target
TGT
$74.7B
$6.76K ﹤0.01%
+10,500
New +$1.01M
WFC icon
1693
PUT
Wells Fargo
WFC
$272B
$6.11K ﹤0.01%
13,200
+3,100
+31% +$224K
C icon
1694
PUT
Citigroup
C
$231B
$3.86K ﹤0.01%
12,800
+2,700
+27% +$195K
GILD icon
1695
PUT
Gilead Sciences
GILD
$187B
$3.42K ﹤0.01%
+12,600
New +$1.34M
KO icon
1696
PUT
Coca-Cola
KO
$379B
$3.35K ﹤0.01%
+11,100
New +$791K
T icon
1697
PUT
AT&T
T
$176B
$2.16K ﹤0.01%
13,400
-16,800
-56% -$463K
NKE icon
1698
PUT
Nike
NKE
$57B
$1.01K ﹤0.01%
+16,700
New +$1M
AGNC icon
1699
AGNC Investment
AGNC
$12.6B
-606,551
Closed -$5.81M
AIV
1700
Aimco
AIV
$372M
-10,188
Closed -$89.7K

Similar funds

Mackenzie Financial's Q2 2025 Portfolio in Review

As of Q2 2025, Mackenzie Financial held 1,822 positions worth $77.2B, up 9.7% from $70.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Mackenzie Financial's Q2 2025 filing shows 156 new, 763 increased, 547 reduced and 123 closed positions. Its largest new stake was Emera Inc: 5,154,300 shares worth $236M. The largest sale was Thermo Fisher Scientific, an estimated $239M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Technology and Industrials.

  • Mackenzie Financial's largest Q2 2025 buy was Emera Inc: 5,154,300 shares worth $236M.
  • Mackenzie Financial added most to Marsh in Q2 2025, an estimated $351M increase.
  • Mackenzie Financial's biggest Q2 2025 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
  • Mackenzie Financial fully exited Dick's Sporting Goods in Q2 2025, selling an estimated $17.9M.
  • Mackenzie Financial's ten largest holdings make up 23% of its $77.2B portfolio in Q2 2025.
  • Mackenzie Financial opened 156 new positions and closed 123 in Q2 2025.
  • Mackenzie Financial's portfolio value rose 9.7% quarter-over-quarter to $77.2B.

Based on Mackenzie Financial's 13F filing for Q2 2025, filed 13 Aug 2025.